Business · 19/08/2004
FDA Releases Guidance on Independent Consultants for Biotechnology Clinical Trials
The Food and Drug Administration (FDA) has made available a document outlining the agency's process for requesting independent consultants to review clinical trial protocols for biotechnology products, finalizing a draft guidance from 2003.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →